Press Release Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President Expansion Therapeutics, Inc., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today…Expansion TherapeuticsOctober 5, 2020
Press Release Expansion Therapeutics Expands Leadership Team with Two Key Appointments; Names World-Renowned Scientist Lynne E. Maquat, Ph.D., to its Scientific Advisory Board Additions strengthen management team and position company to advance portfolio of medicines targeting RNA-mediated diseases…Expansion TherapeuticsJune 17, 2019
Press Release Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer Former EVP of R&D and Chief Medical Officer at Alkermes joins Expansion to advance portfolio…Expansion TherapeuticsNovember 13, 2018
Press Release Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases Names Kevin M. Forrest, Ph.D. President and CEO Proprietary technology based on pioneering work from…Expansion TherapeuticsJanuary 3, 2018